Cullinan Oncology, Inc. (CGEM) Misses Q2 EPS by 25c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q2 EPS of ($1.07), $0.25 worse than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
• Lodestar Metals signs $75,000 investor relations deal with NIA